#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14550	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2052	703.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1649	1649	T	801	T,C	729,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14550	16S	1529	1529	99.93	16S.l15.c30.ctg.1	2052	703.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1383	1383	C	869	C,T	790,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3425	791.5	0	.	n	.	0	C543T	SNP	543	543	C	840	840	T	844	T	795	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3425	791.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1634	1634	A	879	A,G	821,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3425	791.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2268	2268	C	910	C	836	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3425	791.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2342	2342	A	870	A	808	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27232	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3425	791.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2894	2894	C	872	C,A	801,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	88	blaTEM	861	861	99.88	blaTEM.l15.c4.ctg.1	1222	7.1	0	.	p	.	0	M180T	NONSYN	538	540	ATG	720	722	ACG	6;6;7	A;C,T;G	4;3,1;5	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	2070	folP	855	855	99.88	folP.l15.c4.ctg.1	1417	145.3	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	984	986	AGC	191;192;196	A;G;C	176;179;179	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5606	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3397	164.5	0	.	p	.	0	V290I	NONSYN	868	870	GTT	1128	1130	ATT	180;181;182	A,G;T;T,A	170,1;169;171,1	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5606	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3397	164.5	1	SNP	p	S91F	0	.	.	271	273	TCC	531	533	TCC	197;196;200	T;C,A;C	180;175,1;179	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5606	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3397	164.5	1	SNP	p	D95N	0	.	.	283	285	GAC	543	545	GAC	198;198;201	G;A;C	176;180;183	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5606	gyrA	2751	2751	99.82	gyrA.l6.c4.ctg.1	3397	164.5	1	SNP	p	D95G	0	.	.	283	285	GAC	543	545	GAC	198;198;201	G;A;C	176;180;183	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1550	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1199	127.9	1	SNP	p	G45D	1	.	.	133	135	GAC	435	437	GAC	194;193;195	G;A;C,T	181;179;181,1	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	852	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	996	85.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1597	1599	GCA	215;214;213	G;C;A,G	195;187;189,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2080	2082	ATT	221;221;220	A,G;T;T	200,1;201;204	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	1	SNP	p	D86N	0	.	.	256	258	GAC	550	552	GAC	188;188;186	G;A;C	175;176;175	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	1	SNP	p	S87R	0	.	.	259	261	AGT	553	555	AGT	186;185;183	A,C;G;T	173,1;175;173	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	1	SNP	p	S87I	0	.	.	259	261	AGT	553	555	AGT	186;185;183	A,C;G;T	173,1;175;173	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	1	SNP	p	S87W	0	.	.	259	261	AGT	553	555	AGT	186;185;183	A,C;G;T	173,1;175;173	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	5064	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2893	174.4	1	SNP	p	S88P	0	.	.	262	264	TCC	556	558	TCC	182;183;182	T;C;C,A	170;173;173,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4398	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2585	169.3	0	.	p	.	0	H611N	NONSYN	1831	1833	CAC	2111	2113	AAC	226;225;225	A;A;C	200;193;207	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4398	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2585	169.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1508	1510	GGC	222;217;217	G;G;C	199;190;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1293	1295	GCA	237;234;236	G;C;A	221;221;223	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1296	1298	ATC	238;237;242	A;T;C	224;223;228	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1308	1310	GTG	244;245;244	G;T;G	231;227;229	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1308	1310	GTG	244;245;244	G;T;G	231;227;229	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1812	1814	ACC	195;197;198	A;C;C	183;185;184	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1866	1868	GCG	187;188;188	G;C;G	167;155;163	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1866	1868	GCG	187;188;188	G;C;G	167;155;163	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1989	1991	GGT	193;191;191	G;G;T	175;176;171	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1998	2000	GGC	185;184;187	G;G;C	167;165;166	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4220	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2492	169.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2016	2018	CCG	184;187;193	C;C;G	139;164;160	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5966	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2999	198.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1588	1590	CTG	210;212;210	C;T,C;G	183;186,2;182	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2368	porA	1146	1146	99.65	porA.l6.c30.ctg.1	1745	134.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	516	516	C	163	C	157	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	0	.	p	.	0	.	INDELS	629	630	AA	891	893	TAG	253;251;252	T;A;G	228;226;227	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	0	.	p	.	0	.	MULTIPLE	631	633	TAC	895	898	CAAT	254;256;257;258	C;A;A;T	230;236;235;236	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	0	.	p	.	0	N212fs	FSHIFT	634	634	A	900	900	T	254	T	235	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	1	SNP	p	G120K	0	.	.	358	360	GGT	619	621	GGT	201;200;204	G;G;T	191;189;186	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	1	SNP	p	A121D	0	.	.	361	363	GCC	622	624	GCC	203;203;201	G;C;C	191;193;190	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2928	porB1b	1035	1035	98.85	porB1b.l15.c17.ctg.1	1440	201.5	1	SNP	p	A121N	0	.	.	361	363	GCC	622	624	GCC	203;203;201	G;C;C	191;193;190	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10930	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4970	219.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2067	2069	CAT	227;229;231	C;A;T	212;212;213	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1200	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1108	107.7	1	SNP	p	V57M	0	.	.	169	171	GTG	535	537	GTG	261;263;265	G;T;G	242;244;245	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
